Technical Analysis for LMAT - LeMaitre Vascular, Inc.
|Grade||Last Price||% Change||Price Change|
LMAT closed up 1.17 percent on Tuesday, January 15, 2019, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|See historical LMAT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 15||Boomer Sell Setup||Bearish Swing Setup||0.00%|
|Jan 15||Crossed Above 20 DMA||Bullish||0.00%|
|Jan 15||Narrow Range Bar||Range Contraction||0.00%|
|Jan 15||NR7||Range Contraction||0.00%|
|Jan 15||Inside Day||Range Contraction||0.00%|
|Jan 14||20 DMA Resistance||Bearish||1.17%|
|Jan 14||Inside Day||Range Contraction||1.17%|
|Jan 11||Fell Below 20 DMA||Bearish||3.22%|
|Jan 11||180 Bearish Setup||Bearish Swing Setup||3.22%|
|Jan 10||1,2,3 Retracement Bearish||Bearish Swing Setup||-1.64%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
LeMaitre Vascular, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices and implants for the treatment of peripheral vascular disease worldwide. Its products include embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters; perfusion catheters that temporarily perfuse blood and other liquids into the vasculature; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. The company also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, it provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more LMAT news...
|52 Week High||41.28|
|52 Week Low||21.79|
|200-Day Moving Average||32.487|
|50-Day Moving Average||25.4462|
|20-Day Moving Average||23.107|
|10-Day Moving Average||23.002|
|Average True Range||0.9937|
|Chandelier Exit (Long, 3 ATRs )||23.5739|
|Chandelier Exit (Short, 3 ATRs )||24.7711|
|Upper Bollinger Band||24.3009|
|Lower Bollinger Band||21.9131|
|Percent B (%b)||0.63|
|MACD Signal Line||-0.9142|
|Market Cap||445.31 Million|
|Num Shares||19 Million|
|Price-to-Earnings (P/E) Ratio||33.44|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||23.95|
|Resistance 3 (R3)||23.93||23.74||23.86|
|Resistance 2 (R2)||23.74||23.60||23.75||23.83|
|Resistance 1 (R1)||23.57||23.51||23.66||23.59||23.80|
|Support 1 (S1)||23.21||23.24||23.30||23.23||23.02|
|Support 2 (S2)||23.02||23.15||23.03||22.99|
|Support 3 (S3)||22.85||23.02||22.96|
|Support 4 (S4)||22.87|